TY - JOUR
T1 - Proposed Core Outcomes After Neonatal Sepsis A Consensus Statement
AU - Taneri, Petek Eylul
AU - Biesty, Linda
AU - Kirkham, Jamie J.
AU - Molloy, Eleanor J.
AU - Polin, Richard A.
AU - Branagan, Aoife
AU - Kawaza, Kondwani
AU - Daly, Mandy
AU - Wynn, James L.
AU - Bonnard, Lívia Nagy
AU - Quirke, Fiona A.
AU - Kissoon, Niranjan
AU - Ohaja, Magdalena
AU - Bazilio, Kateregga
AU - Giannoni, Eric
AU - Schlapbach, Luregn J.
AU - Suguitani, Denise
AU - Strunk, Tobias
AU - Stoll, Barbara J.
AU - Devane, Declan
N1 - Publisher Copyright:
© 2025 American Medical Association. All rights reserved.
PY - 2025
Y1 - 2025
N2 - IMPORTANCE Sepsis is one of the leading causes of neonatal mortality. There is heterogeneity in the outcomes measured and reported in studies of neonatal sepsis. To address this challenge, a core outcome set (COS) for research on neonatal sepsis was needed. OBJECTIVE The Neonatal Sepsis Core Outcome Set (NESCOS) project aims to develop a COS for research evaluating the effectiveness of neonatal sepsis treatments. EVIDENCE REVIEW For this consensus statement, the research team obtained ethics approval and used a 4-stage process: (1) a systematic review of qualitative studies, (2) a real-time Delphi (RTD) survey to identify important outcomes for consensus meetings, (3) consensus meetings to finalize the COS, and (4) dissemination of the findings. The study was conducted from May 2, 2022, to October 27, 2023. The steering group and project participants consisted of health care workers, researchers, academics, parents, and parent representatives from low-, middle-, and high-income countries. An RTD survey and consensus meetings were conducted, with measures including a 9-point Likert scale rating (where 1 indicated not at all important and 9 indicated critically important) for outcome importance and a minimum 80% agreement threshold among stakeholders for final COS inclusion. The systematic review identified 19 outcomes, which were combined with outcomes from previous systematic reviews of clinical trials. FINDINGS The RTD survey included 306 participants, leading to the identification of 55 outcomes for further discussion in consensus meetings. The finalized COS comprises 9 outcomes: all-cause mortality, need for mechanical ventilation, brain injury on imaging, neurologic status at discharge, escalation of antimicrobial therapy, central nervous system infections, multiorgan dysfunction, neurodevelopmental impairment, and quality of life of parents. CONCLUSIONS AND RELEVANCE This consensus-based COS for research on neonatal sepsis treatments will help standardize the outcomes measured and reported, enhancing the comparability of research findings. Future efforts should focus on establishing standardized and reliable methods for measuring these outcomes.
AB - IMPORTANCE Sepsis is one of the leading causes of neonatal mortality. There is heterogeneity in the outcomes measured and reported in studies of neonatal sepsis. To address this challenge, a core outcome set (COS) for research on neonatal sepsis was needed. OBJECTIVE The Neonatal Sepsis Core Outcome Set (NESCOS) project aims to develop a COS for research evaluating the effectiveness of neonatal sepsis treatments. EVIDENCE REVIEW For this consensus statement, the research team obtained ethics approval and used a 4-stage process: (1) a systematic review of qualitative studies, (2) a real-time Delphi (RTD) survey to identify important outcomes for consensus meetings, (3) consensus meetings to finalize the COS, and (4) dissemination of the findings. The study was conducted from May 2, 2022, to October 27, 2023. The steering group and project participants consisted of health care workers, researchers, academics, parents, and parent representatives from low-, middle-, and high-income countries. An RTD survey and consensus meetings were conducted, with measures including a 9-point Likert scale rating (where 1 indicated not at all important and 9 indicated critically important) for outcome importance and a minimum 80% agreement threshold among stakeholders for final COS inclusion. The systematic review identified 19 outcomes, which were combined with outcomes from previous systematic reviews of clinical trials. FINDINGS The RTD survey included 306 participants, leading to the identification of 55 outcomes for further discussion in consensus meetings. The finalized COS comprises 9 outcomes: all-cause mortality, need for mechanical ventilation, brain injury on imaging, neurologic status at discharge, escalation of antimicrobial therapy, central nervous system infections, multiorgan dysfunction, neurodevelopmental impairment, and quality of life of parents. CONCLUSIONS AND RELEVANCE This consensus-based COS for research on neonatal sepsis treatments will help standardize the outcomes measured and reported, enhancing the comparability of research findings. Future efforts should focus on establishing standardized and reliable methods for measuring these outcomes.
UR - https://www.scopus.com/pages/publications/85219645003
U2 - 10.1001/jamanetworkopen.2024.61554
DO - 10.1001/jamanetworkopen.2024.61554
M3 - Review article
C2 - 39992659
AN - SCOPUS:85219645003
SN - 2574-3805
JO - JAMA Network Open
JF - JAMA Network Open
M1 - e2461554
ER -